In new research just published in a special issue of the Journal of Portfolio Management on factor investing, ERI Scientific Beta has validated the superiority of the top-down approach to multi-factor investing over a bottom-up approach.
The ERI Scientific Beta paper, entitled "Accounting for Cross-Factor Interactions in Multifactor Portfolios without Sacrificing Diversification and Risk Control," compares different approaches for constructing multi-factor equity portfolios: "bottom-up" score-weighting approaches that target high factor intensity and "top-down" approaches that also consider diversification objectives.
The risks and shortcomings of the bottom-up approach are shown to be inefficiency, instability and the inability to control factor exposure and non-factor risks:
- Focusing solely on increasing factor intensity leads to inefficiency in capturing factor premia, as exposure to unrewarded risks more than offsets the benefits of increased factor scores.
- High factor scores in "bottom-up" approaches also come with high instability in factor exposure and high turnover.
- Concentrating portfolios in multi-factor champions can also lead to significant geographical or sector biases.
The authors introduce a new approach that considers cross-factor interactions in "top-down" portfolios through an adjustment at the stock selection level. This approach leads to higher levels of diversification and produces higher returns per unit of factor intensity. The authors report that it dominates "bottom-up" approaches in terms of relative performance, while considerably reducing extreme relative losses and turnover. In addition, this approach preserves the well-known benefits of the top-down approach in terms of explicit and transparent control of exposures to risk factors.
A copy of the article is accessible by clicking on the link below:
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: [email protected], Web: www.scientificbeta.com.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/863b3bf9-fa6b-4d14-b5a7-dcb17cfd0940


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



